Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: A multi-institution study

被引:31
|
作者
Vizza, Enrico [1 ]
Corrado, Giacomo [1 ]
Zanagnolo, Vanna [2 ]
Tomaselli, Tiziana [2 ]
Cutillo, Giuseppe [1 ]
Mancini, Emanuela [1 ]
Maggioni, Angelo [2 ]
机构
[1] Regina Elena Inst Canc Res, Dept Surg Oncol, Gynecol Oncol Unit, Rome, Italy
[2] European Inst Oncol, Cerv Canc Ctr, Dept Gynecol, Milan, Italy
关键词
Robotic radical hysterectomy; Minimally invasive surgery; Locally advanced cervical cancer; Neo-adjuvant chemotherapy; LONG-TERM EFFICACY; RANDOMIZED-TRIAL; PHASE-II; SURGERY; PACLITAXEL; CARCINOMA; CISPLATIN; LYMPHADENECTOMY; CHEMORADIOTHERAPY; IFOSFAMIDE;
D O I
10.1016/j.ygyno.2014.02.035
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Minimally invasive surgery has been performed in locally advanced cervical cancer (LACC) without adverse effect in patient's overall prognosis and survival. The aim of this report is to evaluate the feasibility and morbidity of total robotic radical hysterectomy (TRRH) with pelvic lymphadenectomy in patients with LACC after neo-adjuvant chemotherapy (NACT). Methods. From February 2008 to April 2013 a retrospective data collection of women undergoing TRRH for cervical cancer stage FIGO IB2 to IIB, after neo-adjuvant chemotherapy, was conducted at "Regina Elena" National Cancer Institute of Rome and European Institute of Oncology of Milan. All patients deemed operable underwent TRRH with pelvic lymphadenectomy within 4 weeks from the last chemotherapy cycle. Results. Median operative time was 225 min (range, 105-387 min). The median blood loss was 150 mL (range, 30-700 mL). The median number of removed pelvic lymph nodes was 23 (range, 8-69). Sixteen patients had an optimal response (12 PCR, 4 pPR1) to chemotherapy, 33 patients had a pPR2 and 11 patient showed stable disease. Adjuvant therapy was administrated in 36 patients (60%). We experienced one intra-operative complication and 19 post-operative complications, but no conversions to laparotomy were necessary to manage these complications. Six patients received a blood transfusion. At the time of this report, with a median follow-up of 28.9 months, 50 patients (83%) are free from recurrence. Conclusion. This experience demonstrates the feasibility of TRRH pelvic lymphadenectomy after NACT in LACC with good accuracy and safety. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:180 / 185
页数:6
相关论文
共 50 条
  • [1] NEOADJUVANT CHEMOTHERAPY FOLLOWED BY ROBOTIC RADICAL HYSTERECTOMY IN LOCALLY ADVANCED CERVICAL CANCER: A DOUBLE INSTITUTION STUDY
    Vizza, E.
    Corrado, G.
    Zanagnolo, V.
    Tomaselli, T.
    Cutillo, G.
    Mancini, E.
    Maggioni, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [2] Robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer
    Vizza, Enrico
    Patrizi, Lodovico
    Saltari, Maria
    Sindico, Stefano
    Cimino, Monica
    Corrado, Giacomo
    [J]. MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 2012, 21 (03) : 206 - 209
  • [3] Oncologic outcomes of neoadjuvant chemotherapy followed by radical hysterectomy for locally advanced cervical cancer
    Rush, Margaret
    Nasioudis, Dimitrios
    Ko, Emily
    Haggerty, Ashley
    Cory, Lori
    Giuntoli, Robert
    Kim, Sarah
    Morgan, Mark
    Latif, Nawar
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S163 - S163
  • [4] Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer
    Sugiyama, T
    Nishida, T
    Hasuo, Y
    Fujiyoshi, K
    Yakushiji, M
    [J]. GYNECOLOGIC ONCOLOGY, 1998, 69 (02) : 130 - 136
  • [5] Feasibility of robotic radical hysterectomy after neoadjuvant chemotherapy in women with locally advanced cervical cancer
    Minig, L.
    Zanagnolo, V.
    Cardenas-Rebollo, J. M.
    Colombo, N.
    Maggioni, A.
    [J]. EJSO, 2016, 42 (09): : 1372 - 1377
  • [6] FEASIBILITY OF ROBOTIC RADICAL HYSTERECTOMY AFTER NEOADJUVANT CHEMOTHERAPY IN WOMEN WITH LOCALLY ADVANCED CERVICAL CANCER
    Minig, L.
    Zanagnolo, V.
    Colombo, N.
    Cardenas-Rebollo, J. M.
    Maggioni, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 157 - 158
  • [7] Robotic nerve-sparing radical hysterectomy for locally advanced cervical cancer after neoadjuvant chemotherapy
    Liu, Zhongyu
    Li, Xiuli
    Li, Weiping
    Yang, Yizhuo
    Tao, Ye
    Yao, Yuanqing
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2015, 131 (02) : 152 - 155
  • [8] Laparoscopic versus robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer: A case control study
    Vizza, E.
    Corrado, G.
    Mancini, E.
    Vici, R.
    Sergi, D.
    Baiocco, E.
    Patrizi, L.
    Saltari, M.
    Pomati, G.
    Cutillo, G.
    [J]. EJSO, 2015, 41 (01): : 142 - 147
  • [9] The Outcome of Locally Advanced Cervical Cancer in Patients Treated with Neoadjuvant Chemotherapy Followed by Radical Hysterectomy and Primary Surgery
    Mousavi, Azamsadat
    Gilani, Mitra Modarres
    Akhavan, Setareh
    Hasani, Shahrzad Sheikh
    Alipour, Abbas
    Gholami, Hamideh
    [J]. IRANIAN JOURNAL OF MEDICAL SCIENCES, 2021, 46 (05) : 355 - 363
  • [10] THE OUTCOME OF LOCALLY ADVANCED CERVICAL CANCER IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOLLOWED BY RADICAL HYSTERECTOMY AND PRIMARY SURGERY
    Mousavi, Azam Sadat
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A55 - A55